Journal Article Summary
The article investigates the potential benefits of adding two anti-allergy medications, cetirizine and montelukast, to the treatment regimen of patients with minimal-change nephrotic syndrome (MCNS) who also suffer from allergic disorders. This topic is significant because MCNS is a common cause of nephrotic syndrome, and while corticosteroids are typically effective, many patients experience relapses and side effects from long-term steroid use. Understanding whether anti-allergy treatments can help manage MCNS could lead to improved patient outcomes and reduced reliance on corticosteroids.
The study included 51 patients diagnosed with biopsy-proven MCNS, with 13 receiving cetirizine and montelukast alongside standard treatment, while 38 received conventional therapy only. The researchers used statistical methods to ensure that the two groups were comparable in terms of their clinical characteristics. Key findings indicated that the treatment group had a significant reduction in the lowest daily dose of corticosteroids required to maintain remission compared to their baseline levels. Additionally, a higher percentage of patients in the treatment group achieved a corticosteroid-free state for the first time during the study.
However, the study has limitations, including a small sample size and the fact that it was not a randomized controlled trial, which may affect the reliability of the results. Patients should be aware that while the addition of these medications showed promise in reducing corticosteroid use, further research is needed to confirm these findings in larger and more diverse populations. It is essential for patients to discuss any changes in their treatment plan with their healthcare provider, especially regarding the management of MCNS and any concurrent allergic conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Oshima Yoichi, Sumida Keiichi, Yamanouchi Masayuki, Hayami Noriko, Sekine Akinari, Mizuno Hiroki, Kawada Masahiro, Hiramatsu Rikako, et al.. Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders. Scientific Reports 2020. DOI: 10.1038/s41598-020-58463-z. PMID: 32001777. PMCID: PMC6992583.
Featured Pill Pals Product
Cetirizine 10 mg Tablets - 500 count - Generic For Zyrtec --- DR REDDY
Cetirizine 10 mg Tablets - 500 count - Generic For Zyrtec --- DR REDDY is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
